Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Botanix Pharmaceuticals Limited ( (AU:BOT) ) is now available.
Botanix Pharmaceuticals Limited announced the quotation of 6,928,586 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of May 21, 2025. This move is part of the company’s strategy to enhance its market presence and provide additional liquidity for stakeholders, potentially strengthening its position in the pharmaceutical industry.
More about Botanix Pharmaceuticals Limited
Botanix Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development and commercialization of dermatology and antimicrobial products. The company aims to address unmet needs in skin health and infection control.
Average Trading Volume: 10,602,119
Technical Sentiment Signal: Hold
Current Market Cap: A$732.7M
For a thorough assessment of BOT stock, go to TipRanks’ Stock Analysis page.